ZHEJIANG HUAHAI PHARMACEUTICALS CO LTD

Chinese drugmaker Huahai tumbles after FDA shutout

The drug maker's Shanghai-listed stock fell the maximum allowed 10 percent, its biggest drop in three months, after the company said on Sunday that the move by the U.S. FDA along with regulators in Europe would hit its export business.